Regression of Aflatoxin B 1 -Induced Hepatocellular Carcinomas by Reduced Glutathione
- 1 May 1981
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 212 (4494), 541-542
- https://doi.org/10.1126/science.6782675
Abstract
Reduced glutathione administered to rats bearing aflatoxin B1-induced liver tumors caused regression of tumor growth and resulted in survival of the animals. since glutathione is a harmless natural product, it merits further investigation as a potential antitumor drug for humans.This publication has 9 references indexed in Scilit:
- The Role of Glutathione and Glutathione S-Transferases in the Metabolism of Chemical Carcinogens and Other Electrophilic AgentsAdvances in Cancer Research, 1979
- SOME CURRENT PERSPECTIVES ON CHEMICAL CARCINOGENESIS IN HUMANS AND EXPERIMENTAL-ANIMALS - PRESIDENTIAL-ADDRESS1978
- The mitigating effect of dietary antioxidants on chemically-induced carcinogenesisCellular and Molecular Life Sciences, 1978
- Liver Carcinogenesis in Rats After Aflatoxin B1 AdministrationPublished by Springer Nature ,1977
- TRANSFER-RNA METHYLASE ACTIVITY AND CAPACITY DURING AFLATOXIN B1-INDUCED HEPATOCELLULAR CARCINOGENESIS1976
- Aflatoxin B1 and phenobarbital inducible aflatoxin-Δ2-hydration by rat liver microsomesBiochemical Pharmacology, 1972
- Diurnal Rhythm in Endoplasmic Reticulum of Rat Liver: Electron Microscopic StudyScience, 1972
- Organelle Pathology of the LiverGastroenterology, 1970
- PHENOBARBITAL-INDUCED SYNTHESIS OF THE MICROSOMAL DRUG-METABOLIZING ENZYME SYSTEM AND ITS RELATIONSHIP TO THE PROLIFERATION OF ENDOPLASMIC MEMBRANESThe Journal of cell biology, 1965